Floatz logo

Icosapent Ethyl

Liver Metastasis

Mark A Hull, PhD FRCPPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

15 Active assets in the Liver Metastasis cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
National Taiwan University Hospital
Phase 3BB
Calcium folinate pentahydrate
National Taiwan University Hospital
Phase 3BB
Eloxatin
Tianjin Medical University Cancer Institute and Hospital
Phase 3BB
Talaporfin
Light Sciences LLC
Phase 2BB
Irinotecan
Tianjin Medical University Cancer Institute and Hospital
Phase 3B

View all 30 →

Same molecule, other indications

Icosapent Ethyl is also rated in:

colon carcinomaDormant
B
Indicative ·
56 / 100
View asset →
Alzheimer diseaseDormant
CCC
Indicative ·
55 / 100
View asset →
metastasis from malignant tumor of colonDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →